The Annual General Meeting in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, will be held on Thursday, 9 May, 2019 at 15:00 at Grand Hôtel, S. Blasieholmshamnen 8, Stockholm, Sweden. Registration to the meeting will open at 14:00.

Participation, etc.

Registration Form (in Swedish and for Swedish shareholders only)

Notification of participation can be made as of 3 April, 2019.

Shareholders who wish to attend the Meeting must be recorded in the share register maintained by Euroclear Sweden AB (the Swedish Central Securities Depository) on Friday 3 May, 2019


must notify the company of their intention to participate in the Meeting not later than on Friday, 3 May, 2019

Notification of participation can be made by mail to

Swedish Orphan Biovitrum AB (publ)
“Annual General Meeting”
SE-112 76 Stockholm, Sweden

or by phone to No. +46 8 697 31 91

The notification shall set forth name, address, telephone number (daytime), personal/corporate identity number, the number of shares held and, when applicable, information about representatives and assistants.

Nominee shares

Shareholders, whose shares have been registered in the name of a nominee through the trust department of a bank or similar institution, must, in order to be able to participate in the Meeting, temporarily re-register their shares in their own names in the shareholders’ register maintained by Euroclear Sweden AB as per Friday 3 May, 2019. Shareholders who wish to re-register their shares in their own name should inform their nominee of such re-registration well in advance of this date. 

Proxy etc.

Shareholders represented by proxy shall issue a written and dated power of attorney for the proxy. If the power of attorney is issued on behalf of a legal entity, a certified copy of a registration certificate for the legal entity shall be appended. The power of attorney is valid for one year from the issue thereof or such longer period of time stated in the power of attorney, however not more than five years. A registration certificate shall evidence the circumstances prevailing at the day of the Meeting and should not be older than one year at the time of the Meeting.

The power of attorney in original and, when applicable, the registration certificate, should be submitted to the company by mail at the address indicated above well before the Meeting. A proxy form is held available at this web site, see the list on the right, and will also be sent to shareholders who so request and who inform the company of their postal address. 

Proposals and questions

Shareholders who wish to add items to the AGM agenda or give in proposals to Swedish Orphan Biovitrum’s Nomination Committee have been given the opportunity to do so. 

Considering the scheduled publication date for the Notice of the Annual General Meeting, agenda proposals were to be received by the Company no later than Wednesday, 27 March, 2019, and proposals to the Nomination Committee no later than Thursday, 21 March, 2019. This in order to have sufficient time for including them in the AGM Notice and Agenda respectively.